Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Acalabrutinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Acalabrutinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Acalabrutinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Acalabrutinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Acalabrutinib Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Acalabrutinib intermediate D4 | Stable Isotopes | CS-O-47504 | Not Available | Enquire |
| Acalabrutinib Metabolite (M27) ACP-5862 D4 | Stable Isotopes | CS-O-36984 | 2230757-47-6 (Unlabeled) | Enquire |
| Acalabrutinib-d3 | Stable Isotopes | CS-T-94747 | 1420477-60-6(Unlabelled) | Enquire |
| Acalabrutinib-D4 | Stable Isotopes | CS-CX-00575 | 1420477-60-6 (Unlabeled) | Enquire |
API Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Acalabrutinib | API Standards | CS-AV-00045 | 1420477-60-6 | In Stock |
Metabolites
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 2-methyl-4-oxo Acalabrutinib impurity | Metabolites | CS-O-45112 | 2412166-56-2 | Enquire |
| Acalabrutinib M 37 Metabolite | Metabolites | CS-O-37849 | Not Available | Enquire |
| Acalabrutinib M14 Metabolite | Metabolites | CS-O-37850 | Not Available | Enquire |
| Acalabrutinib M16 Metabolite | Metabolites | CS-O-37804 | Not Available | Enquire |
| Acalabrutinib M2 Metabolite | Metabolites | CS-O-37801 | Not Available | Enquire |
| Acalabrutinib M24 Metabolite | Metabolites | CS-O-37851 | Not Available | Enquire |
| Acalabrutinib M25 Metabolite | Metabolites | CS-O-37800 | Not Available | Enquire |
| Acalabrutinib M3 Metabolite | Metabolites | CS-O-37803 | Not Available | Enquire |
| Acalabrutinib M45 Metabolite | Metabolites | CS-O-37802 | Not Available | Enquire |
| Acalabrutinib Metabolite 1 (ACP-5197) | Metabolites | CS-O-35756 | Not Available | Enquire |
| Acalabrutinib Metabolite 10 (ACP-5461) | Metabolites | CS-O-35758 | Not Available | Enquire |
| Acalabrutinib Metabolite 23 (ACP-5134) | Metabolites | CS-O-35759 | Not Available | Enquire |
| Acalabrutinib Metabolite 27 (ACP-5862) | Metabolites | CS-O-33784 | 2230757-47-6 | Enquire |
| Acalabrutinib Metabolite 5 (ACP-5530) | Metabolites | CS-O-35757 | Not Available | Enquire |
| Acalabrutinib Metabolite 7 (ACP-5531) | Metabolites | CS-O-35760 | Not Available | Enquire |
Impurities
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (S)-4-(8-amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl... | Impurities | CS-O-37316 | 1420478-90-5 | In Stock |
| 1-Bromo-3-(2S)-2-pyrrolidinylimidazo[1,5-a]pyrazin-8-amine | Impurities | CS-O-55612 | 2097168-73-3 | Enquire |
| Acalabrutinib 6-Amide Impurity | Impurities | CS-O-57487 | 1420478-89-2 | Enquire |
| Acalabrutinib 8-Hydroxy impurity | Impurities | CS-O-37319 | Not Available | In Stock |
| Acalabrutinib Acetyl impurity | Impurities | CS-O-37317 | Not Available | Enquire |
| Acalabrutinib Diamide impurity | Impurities | CS-O-37318 | Not Available | Enquire |
| Acalabrutinib Dimer Impurity 2 | Impurities | CS-O-56612 | 723260-09-1 | Enquire |
| Acalabrutinib Impurity 11 | Impurities | CS-O-41255 | 2490433-97-9 | Enquire |
| Acalabrutinib Impurity 12 | Impurities | CS-EO-01300 | Not Available | Enquire |
| Acalabrutinib Impurity 13 | Impurities | CS-EO-01301 | Not Available | Enquire |
| Acalabrutinib Impurity 21 | Impurities | CS-RS-00022 | 1418307-18-2 | Enquire |
| Acalabrutinib Impurity 23 | Impurities | CS-O-43802 | Not Available | Enquire |
| Acalabrutinib Impurity 24 | Impurities | CS-O-43803 | 2198380-46-8 | Enquire |
| Acalabrutinib Impurity 7 | Impurities | CS-EO-00712 | 2180911-32-2 | Enquire |
| Acalabrutinib R-Isomer | Impurities | CS-EO-02265 | 1952316-43-6 | In Stock |
| Acalabrutinib-3,4-dihydropyrrole | Impurities | CS-O-55143 | Not Available | Enquire |
| N-benzylacalabromide | Impurities | CS-O-55144 | Not Available | Enquire |
Building Blocks
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (3,5-Dichloropyrazin-2-yl)methanamine Hydrochloride | Building Blocks | CS-EO-03286 | 2089319-25-3 | Enquire |
| (5-Chloropyrazin-2-yl)methanamine Hydrochloride | Building Blocks | CS-EO-03285 | 1794737-26-0 | Enquire |